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Executive Summary 
2015 is quickly approaching and HIV and maternal mortality remain the two top causes of 
death for women of reproductive age both globally and in sub-Saharan Africa. The year 2015 is 
significant because it represents the target date set by the United Nations (UN) and all its 
member countries to end poverty and hunger; combat HIV, Malaria and other diseases; improve 
maternal health; and significantly reduce child mortality through eight international 
development or Millennium Development Goals (MDGs). These goals, which were officially 
established in 2000 following adoption of the UN Millennium Declaration, aim to encourage the 
world’s poorest countries to reach development milestones through the improvement of social 
and economic conditions. Of the eight goals, MDG 5 aims to improve maternal health through 
the reduction of maternal mortality, and MDG 6 aims to combat HIV, malaria and other diseases 
by reducing disease prevalence and ensuring universal access to treatment and prevention 
services (Appendix A).  
Women in developing countries have on average many more pregnancies than women in 
developed countries, and their lifetime risk of death due to pregnancy is higher. A woman’s 
lifetime risk of maternal death – the probability that a 15 year old woman will eventually die 
from a maternal cause – is 1 in 3800 in developed countries, versus 1 in 150 in developing 
countries. Complications such as post-partum hemorrhage, infections after childbirth, high 
blood pressure during pregnancy (pre-eclampsia and eclampsia), and unsafe abortion account 
for 80 percent of all maternal deaths. The remaining 20 percent are caused by or associated with 
diseases such as HIV and malaria during pregnancy [58]. If the world is going to reach MDG 5 or 
6, all countries must significantly reduce maternal mortality. About 800 women die from 
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pregnancy or childbirth-related complications around the world every day. In 2010, 287,000 
women died during and following pregnancy and childbirth with 99 percent of these 
preventable deaths occurring in developing countries [58].  
Maternal death is the death of a woman while pregnant or within 42 days of termination of 
pregnancy from any cause related to or aggravated by the pregnancy or its management [59]. 
The Maternal Mortality Ratio (MMR) compares the number of maternal deaths in a given year to 
the number of live births occurring in that year. MMR can differ significantly from developed to 
developing countries. The maternal mortality ratio in developing countries averages 240 per 
100,000 live births versus 16 per 100,000 live births in developed countries [58]. Many sub-
Saharan countries such as Central African Republic (890), Sierra Leone (890), Sudan (730), and 
Nigeria (630) still experience high MMR. In Namibia MMR doubled from 225 to 449 per 100,000 
live births between 1992 and 2006/07. This increase translates to an estimated 350 mothers 
dying from pregnancy-related causes every year despite high rates of prenatal care and delivery 
in health facilities [1]. The high number of maternal deaths in developing countries reflects 
inequities in access to health services, and highlights the gap between rich and poor.  
Likewise, HIV/AIDS accounts for 19 percent of all deaths worldwide for women aged 15 - 44 
years [2] and sub-Saharan Africa has the highest proportion of maternal deaths due to HIV (10 
percent). In 2010, of the estimated 19,000 maternal deaths attributed to HIV globally, 17,000 (91 
percent) are in sub-Saharan Africa. For some countries such as Botswana, Lesotho, Namibia, 
South Africa, and Swaziland, MMR increased between 1990 and 2000 mainly as a result of the 
HIV epidemic. In these countries MMR is now declining as antiretroviral therapy (ART) is 
becoming increasingly available [3]. High MMR coupled with a high burden of HIV means that 
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pregnant women are confronted with the dual risks of death associated with advancing HIV 
disease as well as an increased risk of pregnancy-related mortality. By strengthening HIV 
services for pregnant women to include expanded and comprehensive testing, counseling, 
treatment, and care, HIV-related MMRs can be dramatically reduced. Integrated approaches to 
service delivery are needed and will benefit HIV-positive women and their children by providing 
them with improved HIV care and treatment, greater access to reproductive health services, and 
more comprehensive treatment for the prevention of mother-to-child transmission of HIV 
(PMTCT). Measures to improve health outcomes for HIV-positive mothers include expanded 
access to postnatal care including antiretroviral (ARV) prophylaxis, immunizations, and micro 
nutrient supplements. Standard ART typically consists of the combination of at least three ARV 
drugs to maximally suppress the HIV virus and stop the progression of HIV disease. 
One approach to achieving marked reductions in maternal mortality related to HIV is the 
revision of treatment guidelines for HIV-positive pregnant women. In 2006, the World Health 
Organization (WHO) recommended that ARVs be provided to HIV-positive pregnant women in 
the third trimester (beginning at 28 weeks) for PMTCT. At that time, evidence demonstrating the 
protective effect of ARVs during breastfeeding was insufficient. In 2009, the WHO revised its 
treatment PMTCT guidelines to promote ARV use in pregnant women starting at 14 weeks and 
continuing through the end of the breastfeeding period with the goal of reducing MTCT and 
ensuring increased maternal and child survival. Since then, several clinical trials have shown the 
efficacy of ARVs in preventing transmission to the infant while breastfeeding. The two main 
revisions to the WHO’s PMTCT treatment guidelines are: 
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 Lifelong ART for HIV-positive women to maintain their health – a therapy which is also 
safe and effective in reducing MTCT. 
 ARV prophylaxis to prevent MTCT during pregnancy, delivery, and breastfeeding for HIV-
positive women not in need of treatment. 
These are significant changes since revised guidelines propose an earlier initiation of ART for 
HIV infected pregnant women in order to improve their health and prevent MTCT during 
pregnancy, delivery, and breastfeeding. This modification of treatment to introduce ARV therapy 
early for HIV-positive pregnant women will include many women who may not have initially 
qualified for ART. Revised guidelines will also increase the numbers of women who qualify for 
HIV treatment and represent a major shift towards more effective and safer interventions to 
prevent pregnancy complications and HIV transmission during pregnancy, labor and delivery, 
and the postpartum and breastfeeding periods. Primary PMTCT prevention through increased 
access to ARVs can reduce vertical transmission by increasing the proportion of HIV-positive 
women who are provided with comprehensive treatment earlier and for longer periods of time. 
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Introduction 
Since its independence from South Africa in 1990, Namibia has developed politically and socially 
into a middle-income country. Namibia’s successes rest on sound economic management, good 
governance, basic civic freedoms, and respect for human rights, and the country has made 
significant progress in addressing many development challenges.  Its citizens now enjoy access 
to basic education, primary health care services, and safe water. Namibia maintains a social 
safety net for the elderly, disabled, orphans, vulnerable children, and war veterans, and has 
enacted a Social Security Act that provides for maternity leave, sick leave, and medical benefits. 
Despite the above mentioned advances, 62 percent of individuals earning less than $2.00 per 
day and poverty is rampant in both rural and urban areas [67]. Wide disparities in wealth and 
access to resources exist among Namibia’s population of approximately 2,100,000. In 2010, the 
infant mortality rate was 29 per 1,000 live births [4]. Namibian women are having fewer children 
but childbearing often starts early. The total fertility rate (TFR) is the number of children a 
woman is likely to have by the end of her child bearing years according to age-specific fertility 
rates observed in a given year. Namibia’s TFR has declined significantly from 1970 levels of 6.5 
children per woman to 5.2 in 1990 and 3.2 in 2010. TFR variances between rural and urban 
populations have also differed with TFR in both the 2000 and 2010 showing TFR ranging from 
5.1 in rural areas compared with 3.1 in urban areas [55]. According to the WHO, 2010 estimates 
of life expectancy in Namibia was 62 for women and 53 for men which is a decline from 1991 
estimates and may be attributed to the HIV/AIDS epidemic. In 2008, Namibia’s HIV prevalence 
rate was estimated at 17.8 percent among adults ages 15 to 49, which is a decrease from 2006 
estimates of 19.9 percent. Recent health surveys indicate that HIV prevalence is highest (27 
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percent) among adults aged 30-34 years and much lower (5.1 percent) among women aged 15–
19 years [41]. There is a wide differential in life expectancy between the various regions, as well 
as between rural and urban areas. After independence, the Namibian government adopted 
policies and programs to increase access to basic services and improve the health, social, and 
economic well-being of its citizens. A national health policy was also adopted based on universal 
access to health and social services.  
In Namibia, it is the Ministry of Health and Social Services (MoHSS) policy to charge user fees for 
all services except preventive services such as antenatal care (ANC), PMTCT, HIV counseling and 
testing (HCT), postnatal care, family planning (FP), and immunizations [51]. In 2002, the WHO 
estimated that the Namibian government expended 12.9 percent of its annual budget or a per 
capita expenditure of $99 [66]. This amount of public spending on health is still below the 15 
percent required by the Abuja Declaration and government health-related expenditures have 
decreased as a percentage of the overall national budget from 12.7 percent in 2002/03 to 11.3 
percent in 2006/07 [1].  
 In 2004, the total number of physicians in Namibia was 589 or 0.3 per 1,000 population and 
nurses/midwives were estimated at 6,145 or 3.06 per 1,000 population. These ratios are positive 
when compared to sub-Saharan Africa as a whole, which averages 0.2 physicians per 1,000 
population and 1.172 nurses/midwives per 1,000 population. However, HIV prevalence in 
Namibia exceeds 15 percent among adults aged 15-49, which is high when compared to the 
sub-Saharan African average of 7.1 percent. These numbers do not accurately show the situation 
on the ground where private health care facilities are often adequately staffed while staff 
shortages often remain in public sector facilities. The high numbers of adults with HIV, and high 
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prevalence of infections such as malaria and tuberculosis, maternal mortality, child malnutrition 
coupled with the need for expanded preventative services i.e. FP, obstetric care, and childhood 
immunization strain an overburdened health system that has too few or inadequately trained 
health workers. Health workers are often inefficiently distributed so they may not be working in 
the areas where they are most needed [5]. 
Namibia’s health system is organizationally complex with the MoHSS overseeing a system that 
includes both facilities and community based health programs. The 2006/07 Namibia 
Demographic Health Survey (NDHS) found that public health services are provided through a 
system of 30 public district hospitals, 44 health centers, and 265 clinics. One national referral and 
three intermediate hospitals provide support to the district hospitals. Outreach points provide 
basic outreach and act as lower tier health delivery sites due to the vastness of the country, 
population distribution, and lack of access to permanent health facilities in many communities.  
Public sector facilities include hospitals, clinics, and health centers owned and operated by the 
government as well as facilities owned and operated by religious groups but funded by the 
government. Namibia also has private health facilities including hospitals, pharmacies, surgical 
centers and nursing homes that serve approximately 15 percent of the population and are 
mainly located in urban areas [6].  
The WHO estimates that Namibia has approximately 27 hospital beds for every 100,000 
population [61]. Rural households are more likely to be located nearest to a clinic than urban 
households (74 percent and 61 percent, respectively) as well as a health center (9 percent and 4 
percent, respectively). On the other hand, urban households are more likely than rural 
households to be near a government hospital (28 percent and 16 percent, respectively) [6].The 
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WHO estimates that public health care facilities serve 85 percent of the Namibian population 
and are mostly accessed by lower income groups. The private health sector serves the remaining 
15 percent of the population, which is made up of middle and high income groups. Despite the 
apparent large number of health facilities available to the Namibian population, access to health 
care is still a concern for most Namibians due to remoteness and long distances needed to 
reach a health facility.  
According to the 2006/07 NDHS, one in five households is within 15 minutes of a 
government health facility and three in five are within one hour of a health facility. However, 
significant differences in access exist between urban and rural households. The latter are 114 
minutes away from the nearest government health facility, whilst the former are 25 minutes 
away.  Additionally, maternal health services are not consistently available throughout Namibia. 
Nationally, 79 percent of health care facilities (public health centers and clinics) provide ANC 
with only 18 percent of hospitals providing these services. Normal delivery services are available 
in two-thirds, or 67 percent, of facilities, while 71 percent of facilities offer postnatal care. Four-
fifths of all facilities do have a system in place to provide transport to a referral site for maternity 
emergencies, but only 9 percent of facilities nationwide can perform a Caesarean section [51]. 
HIV/AIDS remains a serious public health concern for Namibian women and children. 
Despite its relatively small population of approximately 2,000,000 people, HIV prevalence among 
Namibians aged 15-49 years is estimated at more than 18 percent. In 1990s, the Namibian 
MoHSS in conjunction with local NGOs, donors, and agencies formed the National AIDS Control 
Program (NACP) and expanded the program in 1999 to form the National AIDS Coordination 
Program (NACOP).  This national program coordinates HIV prevention and treatment efforts in 
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Namibia.  All government health facilities (hospitals, health centers, and clinics) distribute 
condoms free of charge, but behavioral patterns such as higher risk sex, multiple and concurrent 
sexual partners, partner violence, and alcohol use remain serious obstacles to improved 
maternal health in Namibia.  
Namibian government health facilities offer provider-initiated testing and counseling (PITC) 
as well as voluntary counseling and testing (VCT) and treatment referral services. Generally, PITC 
is provided in health facilities to increase the number of people who receive VCT, and to identify 
those in need of care and treatment. VCT is typically provided in community based stand-alone 
sites, in outreach as well as health facilities. PITC involves the health care provider specifically 
recommending an HIV test to patients attending health facilities. Under these circumstances, 
once specific pre-test information has been obtained, the HIV test would ordinarily be 
performed unless the patient declines. HCT is generally offered for two purposes—first, as a 
prevention strategy for people who want to know their HIV status and, second, as an entry point 
for treatment, care, and support. PITC is provided in health facilities and VCT is provided in 
community-based stand-alone sites and outreach posts, as well as in health facilities. As of 2009, 
two-thirds of the countries in sub-Saharan Africa, Latin America, and the Caribbean have 
developed HIV testing and counseling policies or guidelines incorporating PITC.  
Since 2002, services have been rolled out to all 34 public hospitals and 206 health facilities and 
clinics. By the end of 2006, all 34 hospitals, state and faith-based organizations, about 178 health 
facilities, were providing PMTCT services; and about 859 health workers were trained in the 
provision of such services. About 68,800 pregnant women had been seen at PMTCT sites as of 
March 2006. About 88 percent of pre-test counseled women took the HIV test, and the HIV 
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prevalence rate among tested women was recorded as 17 percent [6]. By 2007, 256 of the 335 
health facilities in Namibia had ANC services. Of these 256, 74 percent (189 facilities) were 
providing PMTCT services. This translates to a coverage level of 56 percent of all health facilities 
in Namibia in 2007. PMTCT, when integrated into ANC services, makes obtaining PMTCT easier 
and more accessible for pregnant women already attending ANC services. Additionally, the ‘opt-
out’ testing strategies which routinely test all pregnant women for HIV unless a patient explicitly 
refuses the test has accelerated the uptake of PMTCT services.  
The MoHSS adopted opt-out testing for pregnant women in 2002 as a pilot program and 
expanded to all district hospitals in 2006 [55]. Namibia’s 2006-07 Country Report to the UN 
officially listed its rapid testing as an option for PITC in PMTCT, ANC, and TB settings with the 
provision for non-laboratory personnel, including community counselors, to perform rapid 
testing [56]. As a result of the adoption of PITC, 'opt-out' policies, and the use of rapid HIV 
testing with same day results, more than 90 percent of all ANC attendees are tested for and 
counseled on HIV and PMTCT. Of these women, nearly 90 percent receive ART to reduce the risk 
of transmitting the virus to their infants (2010 ANC Sentinel Surveillance Report). 
As of 2011, care and support services for HIV/AIDS clients are available in nine of every 10 
facilities. On average, seven of every 10 facilities offer primary preventive treatment for 
opportunistic infections, such as cotrimoxazole preventive treatment. On average, 18 percent of 
all facilities provide ART services, including seven of every 10 hospitals and a little over one-third 
of health centers. Tools and strategies for ART services, such as national and other clinical 
management guidelines for ART, are widely available in facilities. PMTCT services are available in 
three-quarters of all facilities, including eight of every 10 hospitals and nine of every 10 health 
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centers, however only half of facilities reporting that they offer PMTCT actually offer all five 
components of the minimum PMTCT package. This package includes: counseling and testing for 
pregnant women, short-course preventive ARV for PMTCT, counseling and support for safe 
infant feeding practices, FP counseling or referral, and referral for long-term ART for children 
born to HIV-positive mothers. Nine out of every 10 ANC facilities report offering PMTCT services 
[7]. 
In Namibia, the 2006/07 NHDS indicated that 32 percent of men and 50 percent of women 
have tested and know their HIV status. Among people aged 15-49 years, only 31.3 percent of 
women and 12.9 percent of men have tested and received their results in the past 12 months 
and received their results [10]. Despite these efforts, Namibia has made insufficient progress 
towards achieving MDG 5 and MDG 6. According to the World Bank, HIV prevalence in Namibia 
has increased from four percent in 1990 to 20 percent in 2006 among adults aged 15-49 years 
[8]. In 2007, the total number of women living with HIV who received ARVs to prevent MTCT was 
6,022 and HIV-positive pregnant women needing ARVs to prevent MTCT was approximately 
9,400 [9]. In March 2002, the Namibian Government introduced PMTCT services as a pilot 
project at two state hospitals—Oshakati Hospital in the north and Katutura State Hospital in the 
capital of Windhoek. 
Literature/Evidence Review 
The steady rise in maternal mortality in recent years still poses a major challenge for the 
Namibian health system. The five main preventable causes of maternal mortality are 
hemorrhage, sepsis, unsafe abortion, hypertensive disorders, and obstructed labor. Globally, 
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more than 80 percent of maternal deaths are attributed to these five causes and all can be 
effectively treated at well-staffed, well-equipped health facilities with adequately trained staff 
[63]. In Namibia, maternal mortality is still predominately caused by the low coverage of 
emergency obstetric care services (EmOC) as it relates to MM and HIV/AIDS. EmOC is specific 
care used to save the life of a pregnant woman or her unborn child and includes administration 
of antibiotics, oxytocic, or anticonvulsants for pre-eclampsia or eclampsia for the mother, 
manual removal of placenta or retained placenta, assisted vaginal delivery, surgery or blood 
transfusions [65].Lackluster progress has also been made to reduce infant and under-five 
mortality rates. Since 2000, consistent with the 2006/07 NDHS, the infant mortality rate 
increased from 38 in 2000 to 46 deaths per 1,000 live births in 2006/07. Similarly, under-five 
mortality rose from 62 in 2000 to 69 deaths per 1,000 live births. The main causes of infant 
mortality in Namibia remain HIV/AIDS, inadequate nutrition, and insufficient coverage of 
immunization services [1]. 
The first HIV-infected patient in Namibia was diagnosed in 1986. Since then, the total 
number of HIV infections has grown from 160,000 in 2001 to an estimated 180,000 in 2009 [52]. 
Today, transmission is primarily through heterosexual contact with 2008/09 prevalence 
estimates of 13.3 percent among the general population (ages 15-49 years). Main risk factors for 
HIV in Namibia include multiple concurrent partnerships, inconsistent condom use, low risk 
perception despite high HIV awareness, low levels of male circumcision, high levels of 
transactional sex, and migration [11]. In addition, specific social and gender norms such as inter-
generational sex, alcohol abuse, and gender-based violence conflate the risks faced by 
vulnerable populations.  
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Sentinel surveillance data from ANC sites suggests that HIV prevalence among pregnant 
women has dropped to 17.8 percent in 2008, from a peak of 22 percent in 2002 [53]. AIDS-
related deaths account for approximately 23 percent of all deaths in Namibia (crude death rate 
from population projections for 2008-09). In 2008/09 approximately 5,830 people were newly 
infected with HIV—an average of 16 new infections per day [4]. As stated by the Joint United 
Nations Program on HIV/AIDS (UNAIDS), the average number of AIDs related deaths among 
adults aged 15-49 in Namibia have decreased from approximately 8,500 in 2002 to 
3,900 in 2010 [57]. 
With HIV prevalence still a significant issue among pregnant women in Namibia, improving 
maternal health outcomes during pregnancy, delivery, and the postnatal period is a sure way to 
address HIV infections, transmission, treatment and care.  Actively championing care throughout 
a woman’s care including PMTCT, early introduction of ARVs, and delivery in a health facility will 
prevent and treat the common causes of maternal mortality. In line with the 2006/07 NDHS, 
about 80 percent of live births in Namibia in the five years preceding the survey took place in a 
health facility. Even though 95 percent of pregnant women receive ANC from a skilled provider 
and an additional 70 percent received four or more ANC visits, most women sought care well 
after the first trimester of pregnancy. The majority of women (81 percent) did go to health care 
facilities to give birth but 11 percent of births are assisted by a relative or other untrained 
provider [12].  
MTCT programs were first introduced in 1990 through the United Nations inter-agency 
MTCT Program and numbered nearly 80 programs in 16 countries by 2001. In 1999, an Inter-
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Agency Task Team on PMTCT (IATT) initially comprised of UNAIDS, WHO, UNICEF, and UNFPA 
provided leadership and guidance on PMTCT as part of a broader strategy to prevent the 
transmission of HIV, care for HIV-positive women and their families, and promote maternal and 
child health. The MTCT-Plus Initiative was started in 2001 as a response to UN Secretary General 
Kofi Annan’s “Call to Action” to increase access to HIV/AIDS care and treatment in resource-poor 
settings [13]. The WHO and UNICEF, in collaboration with global partners, have also developed 
the Guidance for Global Scale-up of the Prevention of Mother-to-Child Transmission of HIV to 
provide timely support to countries to accelerate scaling-up of national PMTCT programs. The 
Guidance promotes the integration of PMTCT and links with maternal, newborn and child health, 
ART, FP, and sexually transmitted infection services [64].  
Preventing new HIV infections among pregnant women through increased ARV use during 
pregnancy appears to be a very effective and long-term solution in the push to prevent new HIV 
infections. Successful strategies need to include comprehensive, multi-faceted, and complex 
prevention interventions that address prevailing norms. Additionally, government policies which 
target increased access to HIV care, treatment, and prevention services also need to address and 
meet the needs of people who face elevated risk exposure. Behavior change is required at the 
individual, community, and national levels. All of these changes can be encouraged by creating a 
policy and health care environment that enables individuals to make safer choices, have access 
to care, and sustain healthy behaviors without stigma and financial burden. 
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Program Review 
The Namibia Capacity Building for Country Owned HIV/AIDS Services project (hereafter 
referred to as the project) is a five year project implemented by IntraHealth International and 
funded by the United States Agency for International Development (USAID) with the goal of 
building the capacity of indigenous organizations to implement HIV programs, and improve 
access to high quality HIV prevention, care, support, and treatment services. The project aims to 
increase emphasis on capacity building, quality, and country ownership, reflecting greater 
alignment with the Government of the Republic of Namibia and the US Government priorities 
for improving HIV service delivery, care, and support. The project aims specifically to focus 
technical assistance on systematic capacity building of Namibian faith-based organizations 
(FBOs) including the Anglican Medical Services (AMS), Lifeline/Childline (LL/CL), Catholic Health 
Services (CHS), and Lutheran Medical Services (LMS), as well as the MoHSS, the HIV Clinician’s 
Society, and the Nursing Council of Namibia to sustain comprehensive HIV programs aligned 
with Namibia’s National Strategic Framework (NFS) for HIV AIDS 2010/11 – 2015/16. Faith based 
organizations and their health facilities are integral to the fight against HIV/AIDS in Namibia. 
FBO hospitals and clinics are an integral part of Namibia’s public health care system and service 
more than 25 percent of the Namibian population’s health care needs.   
In order to achieve this goal by 2014, the project is focusing on capacity building and 
country ownership. Strengthened capacity of Namibian FBOs and NGOs will assist in the delivery 
of high quality, comprehensive HIV prevention, care, and treatment services with emphasis on 
maternal, neonatal, and child health (MNCH). The project collaborates with AMS, CHS, and LMS 
to ensure gains are sustained in the implementation of comprehensive, robust HIV programs to 
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improve 1) MNCH service delivery through integration of existing services, 2) support 
implementation of the National Road Map, and 3) ensure partners collaborate closely with the 
MoHSS regional management teams. The project is strengthening partner capacity to routinely 
utilize clinical data for assuring and improving the quality of service delivery in HIV, MNCH, and 
other programs. Increased technical, management, and financial capacity of Namibian FBOs and 
NGOs will better sustain the government’s response to the HIV epidemic.  
Consistent with the MoHSS agenda to eliminate MCTC of HIV, the project implements a 
four-pronged approach to PMTCT with an enhanced focus on primary prevention of HIV 
infection among women of reproductive age; prevention of unintended pregnancies through 
provision of FP; prevention of HIV transmission from HIV-positive women to their infants; and 
provision of appropriate treatment, care, and support to mothers living with HIV and their 
children and families. Ongoing data collection and project reporting cover multiple variables 
and populations affected by, or at risk for, HIV infection. The overall project goal is to analyze 
influencing factors to determine what types of services need to be implemented to increase the 
access and reduce barriers to care, not only by HIV-positive pregnant women but all populations 
at risk of HIV in Namibia.  
Information from data gathered over the life of the project will inform the programmatic 
decision-making of providers, facilities, the project, USAID, and the MoHSS. Data collected and 
analyzed covers the types of services available in facilities, specific populations targeted for care, 
type and duration of treatments, and targeted provider training to increase access to HIV 
prevention, treatment, and care. Data are collected on multiple indicators (Appendix A) in all six 
faith-based health facilities as well as free-standing VCT centers. Intake forms are paper-based 
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but are entered into a corresponding web-based information system. PMTCT specific data are 
collected through ANC, delivery and postnatal registers completed by service providers and 
submitted to the project on a monthly basis through an Epi Info-based system.  
Since 2006, the project has supported the Government of Namibia to reduce the spread and 
impact of HIV by building local capacity. Currently, the project has direct sub‐awards with nine 
local organizations supported by USAID Namibia through the President’s Emergency Plan for 
AIDS Relief (PEPFAR), and supports the activities of the HIV Clinician Society and The 
Pharmaceutical Society of Namibia. Since 2008, the Namibian MoHSS has sought to collaborate 
with non-governmental organizations (NGO) to develop and apply a more technical approach to 
increase its response to HIV/AIDs. Using the NSF for HIV and AIDS Response in Namibia along 
with the National Operational Plan (NOP), Regional Operational Plans (ROPs), and Sector 
Operational Plans (SOPs) which are aligned to the NSF, the government has repositioned 
HIV/AIDS services within a broader primary health care context, integration of HIV and maternal, 
newborn, and child health (MNCH) services, and transferred full leadership and accountability 
for planning, delivering, and assuring the quality of health services to Namibian partners. The 
project utilizes the National Strategy’s recommendations for implementation to assist the 
MoHSS to shift focus from service delivery to greater understanding of how service delivery 
efforts impact the epidemic itself. 
In order to better assist the MoHSS, the project has developed three interrelated technical 
strategies. These include: 1) clinical excellence through evidence-based service delivery, 
mentoring and supportive supervision, and utilization of data to improve performance; 2) 
extension of access to services through increased community referrals and HIV integration with 
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other critical MNCH services; and 3) promotion of organizational leadership and management 
through human resources strengthening, using data for decision making, forming partnerships 
with the private sector, and financial accountability. The project provides targeted technical 
support in HIV clinical services and capacity building in 10 out of 13 regions through direct 
implementation and collaboration with the local partners, the Namibian government, regional 
stakeholders, private providers and other USG implementing partners. The program works to 
aggressively support ART, offer palliative care, rollout counseling and testing services, and scale-
up HIV prevention and behavior change messaging. The project has also assisted the MoHSS to 
deploy an information system that provides human resource and health care managers with 
timely, thorough, and accurate data for decision making.  
Location  
When collecting data, the project has taken into consideration the reporting needs of the 
Namibian Government, USAID, and PEPFAR when data collection is conducted by providers and 
project staff. Indicators 
(Appendix B) have been 
developed in coordination with 
project staff, USAID, and host 
government input. Since 2008, 
the project and MoHSS have 
collaborated to reduce maternal 
mortality through technical 
Facility sites 
supported 
by the 
Namibia 
Capacity 
Building for 
Country 
Owned 
HIV/AIDS 
Services 
Project 
Source: IntraHealth International 2012. 
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assistance in EmOC, PMTCT in antenatal clinics, labor and delivery wards, and surrounding 
communities of faith-based facilities (five out of 33 national hospitals and one health center) in 
10 of the 13 regions of Namibia. By the end of 2011, the project has supported PMTCT services 
in 56 health facilities in and around mission facilities. These sites include the six faith-based 
facilities cited above plus 50 other public facilities in surrounding communities that fall under 
partner organization management. This level of coverage leaves only seven facilities targeted by 
the project not yet offering PMTCT.  
Population 
Targeted data are being collected in project supported facilities on 1) pregnant women with 
known HIV status, 2) People Living with HIV (PLHIV), 3) individuals participating in preventive 
interventions, 4) individuals reached through community outreach that promotes HIV/AIDS 
prevention through other behavior change beyond abstinence and/or being faithful, 5) 
individuals who received testing and counseling at public and faith-based health facilities, 6) 
infants born to HIV-positive mothers less than 12 months of age, and 7) children eligible for HIV 
services (the WHO recommends universal ARV treatment for children <2 years born to HIV-
positive mothers regardless of CD4 count or clinical data. For children >2, CD4 or clinical data 
are recommended. For the project’s purposes, facilities are defined as health clinics, health 
centers, district and intermediate hospitals established and funded by the government, and 
private health clinics established and funded by FBOs. Depending on the level in the health 
system, health clinics are staffed by a midwife, nurse, doctor, or combination of the three.   
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Techniques 
Under the project, PMTCT is aimed at reducing the HIV incidence related to vertical 
transmission by increasing the proportion of HIV-positive women and their exposed babies 
provided with ARV prophylaxis. Ensuring availability of ARV drugs to mothers and their 
newborns, safe childbirth, infant feeding counseling, FP counseling/referral and continuity of 
care are the key components of project-supported PMTCT programs in facilities. These 
interventions are accessed through antenatal clinics and labor and delivery wards in six mission 
facilities (five faith-based hospitals and one health center). Health facility-based information 
systems for PMTCT track a wide range of data on patients receiving care at faith-based partner 
facilities. In general, patients receiving services have information collected on paper-based 
passport and registers. The data are then entered into health information systems from which 
monthly reports are being produced. Each month, reports are generated by health facility staff, 
aggregating individual patient data on key indicators and stratified according to the 
disaggregation, including gender and age. Monthly data are sent to the project, which 
aggregates this information quarterly.  
Data Collection Systems 
The project is responsible for monitoring and evaluating the program, including the local 
partners’ activities, and routinely records data through data collection tools such as patient 
registers, monthly health information system (HIS) reports, quarterly data reports, and quarterly 
performance benchmark reports on the services provided. Data are collected from 
clients/patients on a daily basis and then collated onto the monthly summary form. The monthly 
summary form or dataset is submitted to Project Managers, the MoHSS, and other relevant 
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partners. The project collates data received from partner organizations, analyzes and uses the 
data for reporting, completes the quarterly template and narrative, and submits these forms to 
USAID. Electronic reports are disseminated on a regular basis via feedback and planning 
workshops.  
Reporting Procedures 
The reporting framework for performance monitoring utilizes existing data flow for facility-
based reporting through district and regional teams, as well as national offices for the partner 
organizations. The existing MoHSS HIV Information System collects monthly information on 
relevant indicators as required by partner organizations. Information collected and collated from 
all partner organizations, program reviews, evaluations, and other consultative exercises are 
compiled into reports and other information products for sharing, dissemination, and 
documentation. Partner organizations submit monthly reports and data to the project by the 5th 
of every month and the quarterly report by the 10th of the month following the end of the 
quarter; therefore facilities/sites submit their reports and data to their head offices in advance of 
these deadlines. On the 5th of every month, the project M&E officer reviews reports with 
partners to ensure timeliness, completeness, accuracy, reliability, and validity of reports. 
Problems encountered are discussed via telephone and/or email. Reports are submitted to the 
technical director within ten days of receipt for further review and analysis.  
Results  
In Namibia, PMTCT was first introduced in 2005 as part of the MoHSS national roll-out to 
health centers and clinics. PMTCT programs were strengthened through USAID-supported 
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projects, which have helped to recruit and train nurses, medical doctors, community health 
workers, and counselors to carry out routine HCT for all pregnant women coming to health 
clinics for prenatal care and delivery as well as those mothers who deliver with unknown status. 
Both HIV-positive mothers and their newborns are now routinely offered ARV prophylaxis 
according to national guidelines in addition to counseling and support for maternal nutrition, 
safe infant feeding, FP counseling and referrals, and ANC routine services.  
PMTCT: The project supports faith-based partners to offer and strengthen quality PMTCT 
services at district hospitals, gradually extending professional care providers into the community 
for follow-up care of HIV-positive women, babies, and children at 48 satellite facilities. The 
project has exceeded its overall target for the number of pregnant women with known HIV 
status (includes women who were tested for HIV and received their results) in each of the four 
preceding project years (2008-2012). This is partly due to the national increase in the number of 
HIV testing sites with rapid testing capabilities, which reached 275 out of a total of 343 facilities 
or a coverage rate of 80 percent for 2010/2011 [57]. As a result of the increased number of 
facilities which can offer rapid testing, more women are counseled, tested, and receive their 
results on the same day. The project also exceeded targets for the number of HIV-positive 
pregnant women who received ARVs to reduce risk of MTCT. During 2008/09, a total of 1,728 
HIV-positive women delivered in project supported facilities, of which 292 (or 17 percent) 
received ART, and 1,347 (or 78 percent) received ARVs. The project is working to integrate FP, 
gender, and HIV services by offering referrals, couples counseling and testing, and access to 
legal, psychosocial, and income-generating agencies for HIV-positive women.   
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ART: The project is currently supporting local partners to provide 16,120 HIV-positive persons 
with ART. A total of 3,230 patients began ART in 2008/2009, and a 77 percent continuation rate 
for all patients initiating ART is a result of rigorous adherence counseling, support group 
activities and active defaulter tracing. The project continues to support decentralization of 
services to satellite health facilities for clinically stable patients via integrated management of 
adult and adolescent illnesses (IMAI) by task-shifting appropriate HIV/AIDS procedures to lower-
level cadres.  
Brief Motivational Intervention (BMI): Alcohol abuse is widely viewed as one of the main 
drivers of the HIV epidemic in Namibia.  WHO data from 2003 to 2005 showed that annual 
alcohol consumption in Namibia per capita was 9.6 liters, well over the average consumption in 
Africa (6.2 liters) [60]. Drinking alcohol has been shown to lower condom use and encourage 
earlier sexual debut as well as putting partners at higher risk for multiple concurrent partners, 
casual partners, and more at-risk partners. Additionally, informal establishments which sell 
alcohol often double as locations to have sex.  
The BMI approach involves screening for alcohol use and assesses the willingness of the client to 
address drinking behavior. Using BMI skills, PMTCT counselors have a platform to enter into an 
in-depth dialogue with mothers where women are respected, acknowledged, appreciated, and 
given freedom to make an informed choice. Mothers are also able to tell their own stories and 
express their feelings in a safe and judgment-free environment.  A key component of BMI is the 
development of an alcohol reduction plan for those showing interest in changing behavior. The 
project conducts quarterly supervisory visits to each site, which enables continuous assessment 
of, and support to, each facility. In addition, project staff organizes semi-annual performance 
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reviews where partners share achievements, identify lessons learned and best practices, and 
discuss challenges. 
HIV Counseling and Testing: Project-supported HCT program has successfully scaled up 
outreach testing services in conjunction with the MoHSS. During 2009, a total of 75,320 
individuals and 7,311 couples were tested and counseled (89 percent first-time testers). The 
project prevention team conducted a series of trainings with community mobilizers to increase 
uptake at VCT centers, which resulted in an increase in outreach testing events, community 
mobilization, and the number of people tested. Performance support and quality improvement 
visits are conducted quarterly with 18 community mobilizers and site managers with emphasis 
placed on the community mobilizers’ role as the forerunners for all outreach/mobile HCT. PITC is 
an opportunity to normalize HIV testing by making it routine; collaborations with the 
MoHSS/National Health Training Center to conduct PITC trainings targeting all health care 
providers and counselors providing services in health facilities are a way to make HIV testing an 
essential component of the diagnostic process. Finalization of the national HCT guidelines is 
another way to ensure that patients with sexually transmitted infections (STIs), FP clients, 
pregnant women, and adult inpatients and their families will be prioritized to receive PICT. To 
date, between 95 and 100 percent of all STI, and ANC clients offered PITC accept testing.  
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Discussion/Recommendations 
In 2000, the WHO issued revised recommendations on the use of ARVs for PMTCT. These 
revisions expanded successful ART programs by simplifying and standardizing treatment 
regimens during pregnancy. These programs focused on primary prevention of HIV infection 
among women and their partners; prevention of unintended pregnancies among HIV-infected 
women; prevention of HIV transmission from HIV-infected women to their children; and the 
provision of treatment, care, and support for women living with HIV/AIDS, their children, and 
families [14]. Through these programs, HIV-positive pregnant women have greater access to 
ARV drugs which treat their HIV infection and prevent HIV transmission to their infants. Early 
ARV treatment benefits not only the health of HIV-positive pregnant women but also 
substantially reduces the risk of MTCT. 
Namibia, like most sub-Saharan African countries, is dealing with multiple health issues 
including HIV infection, health care worker shortages, maternal, infant and child mortality, and 
child malnutrition. With MMR currently at 449 deaths per 1,000 live births in Namibia and HIV 
prevalence around 18 percent among women of reproductive age, health care workers, women, 
government, and communities need to better understand and address the interrelated nature of 
HIV and maternal mortality [12]. Early ARV treatment for all women who are HIV-positive 
regardless of their current HIV condition could improve the health status of pregnant HIV-
positive women.  
The good news is that Namibia has been able to reverse its high MMR through the 
introduction of ARVs for HIV-positive pregnant women. The country’s commitment and efforts 
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to reach MDG 5 are starting to pay off, but bold commitment is still needed to reduce maternal 
mortality by three-quarters by 2015. Namibia has made strides to address maternal mortality 
through its Vision 2030 and National Development Plans, which focus the Government of 
Namibia commitment to the overall health of its people and particularly maternal health. 
Practical guidelines such as the Roadmap to Maternal, Newborn, and Child Health support the 
implementation of policies which aim to directly improve maternal and child health throughout 
the country. 
ANC is an important first point of contact for providers to reach pregnant women and 
counsel them about HIV risks, testing, treatment, and care. On average pregnant women attend 
their first visit in the second or third trimester and overall utilization of postnatal care is low. 
Addressing insufficient coverage of basic emergency obstetric care facilities, especially in the 
northern regions of Namibia, could have a measurable impact on positive pregnancy outcomes 
and reductions of maternal mortality. Since most pregnant women in Namibia have at least four 
ANC visits in accordance with the WHO standards, and deliver in health facilities by skilled birth 
attendants (SBAs), the MoHSS could regain missed opportunities for HIV care and treatment 
during pregnancy.  Appropriate strategies where missed opportunities could encourage uptake 
of HIV care and treatment are opt-out testing, coupling testing, and treatment of common 
pregnancy related complications such as anemia, vitamin A deficiency, and pre-eclampsia. Going 
forward, obstetric outcomes for HIV-positive women could be improved if particular attention is 
paid to areas where HIV and ANC access and coverage are low and mortality higher. 
Despite an increase in the number of pregnant women who know their HIV status globally, 
and earlier initiation of ARVs for these women, decreases in maternal deaths are not being 
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observed. One approach to make a meaningful impact in the rate of maternal and child 
mortality is the strengthening of HIV services to ARV expansion for HIV-positive pregnant 
women. This will provide an opportunity for the Namibian health system to alter the HIV 
epidemic trajectory, and reduce maternal and child deaths related to HIV infection. Specifically, 
the Namibian Government could ensure that the national health system has the resources and 
staffs to make sure all HIV pregnant women who need ARV treatment for their own health 
receive it in accordance with the WHO guidelines. The use of ARV treatment during pregnancy, 
when indicated, substantially benefits the health of the woman and decreases the risk of HIV 
transmission to the infant. 
Additionally, HIV-positive pregnant women who do not have indications for ARV treatment, 
or do not have access to treatment, should be offered ARV prophylaxis for PMTCT using 
approved ARV regimens. Through expanded access to PMTCT programs, the Namibian 
government and health care system could ensure that all eligible HIV-positive pregnant women 
have access to ARV treatment. Decisions relating to ARV treatment for pregnant women should 
be based on their need and eligibility and not rely on access or economic considerations since 
ARV drugs should be taken in the first trimester of pregnancy, before a woman is typically aware 
that she is pregnant, in order to prevent PMTCT [16]. Several approaches which could address 
and reduce barriers to expanded ARV treatment include:   
 Greater integration of PMTCT services into other programs, such as immunizations and 
FP, could reduce a woman’s fear of discrimination and stigma due to her HIV status 
when accessing PMTCT services.  
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 Increase education on WHO-recommended infant feeding practices to address the low 
adherence to breastfeeding which endorses either full breastfeeding for the first 4-6 
months and rapid weaning, or full artificial feeding. 
 Increase support to women who deliver at home through more community outreach and 
education to increase the uptake of ARVs for HIV prevention since many women attend 
antenatal clinics for care during pregnancy but do not deliver in health facilities.  
 Increase family and community involvement in the design and tailoring of PMTCT service 
delivery options to help normalize and increase use of HIV counseling, testing, 
treatment, and care.  
 Increase national, regional and local political commitment and leadership to make 
PMTCT a foundation service of the ANC care package.  
For countries with high HIV prevalence, such as Namibia, HIV has become a leading cause of 
death for women during pregnancy and the postpartum period. Despite an initial increase in 
maternal mortality in Southern Africa between 1990 and 2005, there is evidence that declines 
noted between 2005 and 2010 are due to increased access and treatment of HIV-positive 
women using ARVs during pregnancy. The increased use of ART by HIV-positive women in sub-
Saharan Africa, from <10 percent in 2000 to 55 percent in 2010, has reduced maternal mortality 
due to HIV [3, 13]. In September 2010, the UN Secretary-General launched the Global Strategy 
for Women’s and Children’s Health to mobilize commitments by governments, civil society 
organizations and development partnerships to accelerate progress toward achieving MDGs 
related to maternal mortality.  
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Key strategies countries could implement as part of HIV prevention, care, and treatment 
programs to improve maternal health and reduce maternal mortality could include 1) support 
for country-led health plans funded by increased, predictable, and sustainable investment; 2)  
integrated delivery of health services and life-saving interventions so that women can access 
prevention, treatment and care; 4) stronger health systems with sufficient skilled health workers; 
5) health workforce capacity to deal with increased disease burden, care, and treatment; and 6) 
innovative approaches to financing, product development, and efficient health service delivery 
[17]. Applying these strategies to all aspects of maternal health would provide a greater impact 
on the causes of maternal mortality including those related to HIV while helping to improve 
national scale-up of best practices. Removing barriers to needed prevention, care and treatment 
will ensure that women in Namibia, and around the globe, receive comprehensive health care by 
skilled providers when and where they need it.  
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Goals and Targets (from the Millennium Declaration) Indicators for monitoring progress 
Goal 5: Improve maternal health  
Target 5.A: Reduce by three quarters, 
between 1990 and 2015, the maternal 
mortality ratio 
5.1 Maternal mortality ratio 
5.2 Proportion of births attended by skilled health personnel  
Target 5.B: Achieve, by 2015, universal 
access to reproductive health 
5.3 Contraceptive prevalence rate  
5.4 Adolescent birth rate 
5.5 ANC coverage (at least one visit and at least four visits) 
5.6 Unmet need for FP  
Goal 6: Combat HIV/AIDS, malaria and other diseases 
Target 6.A: Have halted by 2015 and 
begun to reverse the spread of 
HIV/AIDS 
6.1 HIV prevalence among population aged 15-24 years  
6.2 Condom use at last high-risk sex 
6.3 Proportion of population aged 15-24 years with comprehensive correct knowledge of HIV/AIDS 
6.4 Ratio of school attendance of orphans to school attendance of non-orphans aged 10-14 years 
Target 6.B: Achieve, by 2010, universal 
access to treatment for HIV/AIDS for all 
those who need it 
6.5 Proportion of population with advanced HIV infection with access to antiretroviral drugs 
Target 6.C: Have halted by 2015 and 
begun to reverse the incidence of 
malaria and other major diseases 
6.6     Incidence and death rates associated with malaria 
6.7 Proportion of children under 5 sleeping under insecticide-treated bed nets 
6.8 Proportion of children under 5 with fever who are treated with appropriate anti-malarial drugs 
6.9     Incidence, prevalence and death rates associated with tuberculosis 
6.10 Proportion of tuberculosis cases detected and cured under directly observed treatment  short 
course  
Appendix A: Millennium Development Goals 5 and 6 
  
 
Source: United Nations Millennium Development Goals Indicators 2008 
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Appendix B: Project HIV Indicators  
Service Area Indicator 
PMTCT 
Number of pregnant women with known HIV status (includes women who 
were tested for HIV and received their results)  
Number of HIV-positive pregnant women who received antiretroviral to 
reduce risk of mother-to-child-transmission 
Number of health facilities providing ANC services that provide both on-site 
HIV testing and ARVs for PMTCT    
Number of HIV-positive pregnant women assessed for ART eligibility through 
either clinical staging (using WHO clinical staging criteria) or CD4 testing  
Number of HIV-positive pregnant women newly enrolled into HIV care and 
support services  
Number of health care workers who successfully completed an in-service 
training program in providing PMTCT services 
Post-Exposure 
Prophylaxis 
Number of persons provided with post-exposure prophylaxis (PEP)  
Number of health care workers who successfully completed an in-service 
training program in Post-exposure prophylaxis 
Prevention with 
People Living with 
HIV (PwPLHIV) 
Number of PLHIV reached with a package of PLHIV (PwP) interventions that 
meet the minimum standards required  
Number of health care workers who successfully completed an in-service 
training program in providing prevention with PLHIV 
Sexual and other 
Behavioral Risk 
Prevention 
Number of the targeted population reached with individual and/or small 
group level (<25 people) preventive interventions that are based on evidence 
and/or meet the minimum standards required  
Number of the targeted population reached with individual and/or small 
group level (<25 people) preventive interventions that are primarily focused 
on abstinence and/or being faithful, and are based on evidence and/or meet 
the minimum standards required  
# of individuals reached through community outreach that promotes 
HIV/AIDS prevention through other behavior change beyond abstinence 
and/or being faithful (CM) 
Number of individuals who successfully completed an in-service training 
program in providing sexual & behavioral risk prevention interventions 
Testing and 
Counseling 
Number of individuals who received Testing and Counseling (T&C) services for 
HIV and received their test results  
Number of HCT outreach/mobile outlets established 
Number of individuals who successfully completed an in-service training 
program in testing & counseling    
Umbrella Care Number of eligible adults and children provided with a minimum of one care 
Carol Cissé 
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Service Area Indicator 
service 
Clinical Care 
Number of HIV-positive adults and children receiving a minimum of one 
clinical service  
Number of HIV-positive persons receiving cotrimoxazole prophylaxis  
TB/HIV: % of HIV-positive patients who were screened for TB in HIV care or 
treatment settings  
TB/HIV: % of HIV-positive patients in HIV care or treatment (pre-ART or ART) 
who started TB treatment  
TB/HIV: Number of eligible HIV-positive patients starting Isoniazid Preventive 
Therapy (IPT)  
Number of health care workers who successfully completed an in-service 
training program IN CLINICAL CARE FOR PLHIV 
Pediatric Care 
% of infants born to HIV-positive women who received an HIV test within 12 
months of birth 
% of infants born to HIV-positive pregnant women who are started on CTX 
prophylaxis within two months of birth 
Support Care 
Number of eligible adults and children provided with psychological, social, or 
spiritual support 
Number of individuals who successfully completed an in-service training 
program IN SUPPORT CARE FOR ADULTS 
Treatment  
Number of adults and children with advanced HIV infection newly enrolled on 
ART    
Number of adults and children with advanced HIV infection receiving ART 
% of adults and children known to be alive and on treatment 12 months after 
ART initiation 
Number of adults and children with advanced HIV-infection who ever started 
on ART  
Number of public health facilities that offer ART  
Number of health care workers who successfully completed an in-service 
training program IN PROVIDING ADULT ART 
Number of health care workers who successfully completed an in-service 
training program IN PROVIDING ART TO PEDIATRICS 
 
Source: IntraHealth International 2008  
